Steve Foots Purchases 5 Shares of Croda International (LON:CRDA) Stock

Croda International Plc (LON:CRDAGet Free Report) insider Steve Foots bought 5 shares of the business’s stock in a transaction that occurred on Friday, July 10th. The stock was acquired at an average cost of GBX 2,859 per share, with a total value of £142.95.

Steve Foots also recently made the following trade(s):

  • On Wednesday, June 10th, Steve Foots acquired 5 shares of Croda International stock. The shares were acquired at an average price of GBX 2,965 per share, with a total value of £148.25.
  • On Monday, May 11th, Steve Foots bought 5 shares of Croda International stock. The stock was acquired at an average price of GBX 2,850 per share, for a total transaction of £142.50.
  • On Tuesday, May 5th, Steve Foots sold 73 shares of Croda International stock. The shares were sold at an average price of GBX 2,840, for a total transaction of £2,073.20.

Croda International Trading Up 0.1%

CRDA traded up GBX 3 on Monday, hitting GBX 2,900. The company had a trading volume of 625,996 shares, compared to its average volume of 4,506,491. The company has a market cap of £4.04 billion, a PE ratio of 65.32, a PEG ratio of 1.40 and a beta of 0.92. Croda International Plc has a 12-month low of GBX 2,426.77 and a 12-month high of GBX 3,312. The company has a quick ratio of 2.25, a current ratio of 1.99 and a debt-to-equity ratio of 31.85. The business’s fifty day simple moving average is GBX 2,958.08 and its 200 day simple moving average is GBX 2,884.18.

Analyst Ratings Changes

CRDA has been the topic of several analyst reports. Morgan Stanley raised Croda International to an “overweight” rating and boosted their target price for the company from GBX 3,280 to GBX 3,350 in a research report on Wednesday, March 25th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Croda International from GBX 3,100 to GBX 3,000 and set a “hold” rating for the company in a research note on Tuesday, March 24th. Finally, Jefferies Financial Group restated a “hold” rating and issued a GBX 3,000 target price on shares of Croda International in a report on Wednesday, April 22nd. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Croda International has a consensus rating of “Moderate Buy” and an average target price of GBX 3,140.

Read Our Latest Report on CRDA

Croda International Company Profile

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

Read More

Insider Buying and Selling by Quarter for Croda International (LON:CRDA)

Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.